Rojas-Bartolomé Laura, Payá María, Barbella-Aponte Rosa, Restrepo Carvajal Laura, García-García Jorge, Ayo-Martín Oscar, Molina-Nuevo Juan David, Serrano-Heras Gemma, Juliá-Molla Enrique, Pedrosa-Jiménez María José, López-Martínez Lorena, Fernández López Ángela, Segura Tomás, Hernández-Fernández Francisco
Department of Neurology, University General Hospital of Albacete, Albacete, Spain.
Department of Surgical Pathology, University General Hospital of Albacete, Albacete, Spain.
Front Neurol. 2025 Mar 20;16:1563371. doi: 10.3389/fneur.2025.1563371. eCollection 2025.
Clot composition appears to be associated with outcomes in stroke recanalization therapy. This study aims to analyze thrombus composition and assess the relationship between atypical clot composition and clinical parameters, laboratory markers, and recanalization strategies in a series of patients with acute ischemic stroke (AIS) undergoing endovascular treatment (EVT).
This is a prospective single-center registry conducted from December 2014 to July 2022. All retrieved clots were examined under an established protocol and classified as follows: red blood cell-rich clots (RBC), fibrin/platelet-rich clots (FPC), mixed clots (MC), septic emboli (SE), atheroma emboli (AE), fatty emboli (FE), and calcium emboli (CE). We categorized them into two groups: atypical clot composition (ACC: SE, AE, FE, and CE) and usual clot composition (UCC: RBC, FPC, and MC). A subgroup of 10 ACC (four SE, three AE, two FE, and one CE) and nine UCC (three RBC, three FPC, and three MC), matched by age and sex, was analyzed using immunohistochemistry to detect neutrophil extracellular traps (NETs).
A total of 606 patients were assessed for EVT, with 448 (73.92%) meeting the inclusion criteria. The clot categorization was as follows: FPC 211 (47.1%), RBC 105 (23.4%), MC 104 (23.2%), SE 16 (3.6%), AE 5 (1.1%), CE 4 (0.9%), and FE 3 (0.7%). Consequently, we classified 420 (93.75%) patients into the UCC group and 28 (6.25%) into the ACC group. Bivariate analysis revealed that the ACC group had a significantly higher number of leukocytes (11.40 leukocytes/mm vs. 9.49, = 0.005), a greater frequency of TICA occlusion (28.6% vs. 9.8%, = 0.006), and higher mortality at three months (28.6% vs. 12.4%, = 0.038). Multivariate analysis indicated that atypical clot composition was significantly associated with a higher prevalence of diabetes mellitus, smoking, occlusion of the terminal internal carotid artery, and an increased number of passes. Immunohistochemical studies showed the presence of neutrophil extracellular traps (NETs) in all 19 thrombi that were analyzed.
Diabetes and TICA occlusion were the strongest predictors of atypical clot composition. We also observed a significant association between atypical composition and an increased number of passes. Furthermore, the presence of NETs in all thrombi analyzed, regardless of their composition, indicates inflammatory mechanisms associated with clot formation and consolidation in AIS.
血栓成分似乎与中风再通治疗的结果相关。本研究旨在分析一系列接受血管内治疗(EVT)的急性缺血性中风(AIS)患者的血栓成分,并评估非典型血栓成分与临床参数、实验室指标以及再通策略之间的关系。
这是一项于2014年12月至2022年7月进行的前瞻性单中心登记研究。所有取出的血栓均按照既定方案进行检查,并分类如下:富含红细胞的血栓(RBC)、富含纤维蛋白/血小板的血栓(FPC)、混合血栓(MC)、脓毒性栓子(SE)、动脉粥样硬化栓子(AE)、脂肪栓子(FE)和钙栓子(CE)。我们将它们分为两组:非典型血栓成分(ACC:SE、AE、FE和CE)和常见血栓成分(UCC:RBC、FPC和MC)。通过年龄和性别匹配,对10例ACC(4例SE、3例AE、2例FE和1例CE)和9例UCC(3例RBC、3例FPC和3例MC)亚组进行免疫组织化学分析,以检测中性粒细胞胞外陷阱(NETs)。
共有606例患者接受了EVT评估,其中448例(73.92%)符合纳入标准。血栓分类如下:FPC 211例(47.1%)、RBC 105例(23.4%)、MC 104例(23.2%)、SE 16例(3.6%)、AE 5例(1.1%)、CE 4例(0.9%)和FE 3例(0.7%)。因此,我们将420例(93.75%)患者分类为UCC组,28例(6.25%)患者分类为ACC组。双变量分析显示,ACC组的白细胞数量显著更高(11.40个白细胞/mm³对9.49个,P = 0.005),大脑中动脉M1段闭塞的频率更高(28.6%对9.8%,P = 0.006),且三个月时的死亡率更高(28.6%对12.4%,P = 0.038)。多变量分析表明,非典型血栓成分与糖尿病、吸烟、颈内动脉末端闭塞的患病率较高以及操作次数增加显著相关。免疫组织化学研究显示,在所有19个分析的血栓中均存在中性粒细胞胞外陷阱(NETs)。
糖尿病和大脑中动脉M1段闭塞是非典型血栓成分的最强预测因素。我们还观察到非典型成分与操作次数增加之间存在显著关联。此外,在所有分析的血栓中均存在NETs,无论其成分如何,这表明AIS中与血栓形成和巩固相关的炎症机制。